Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

740
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
740
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

667
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
667
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

479
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
479
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

400
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
400
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.6K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Impact of Daily Rhythms and Postprandial Responses on the Plasma Metabolome.

International journal of molecular sciences·2026
Same author

CV risk: if you aren't testing ACR, you aren't seeing the full picture.

Postgraduate medicine·2026
Same author

Diversion of Arginine's dietary metabolic fate in proteinuric kidney disease.

Research square·2026
Same author

The impact of multiple long-term conditions on mortality, progression to kidney failure and health-related quality of life among people with chronic kidney disease: a multicentre cohort study (NURTuRE-CKD).

Annals of medicine·2026
Same author

Cardiovascular-Kidney-Metabolic Syndrome: Conceptualising an Approach to Health Economic Modelling.

Diabetes, obesity & metabolism·2026
Same author

Environmental pollution, apolipoprotein A-1 autoantibodies and cardiovascular risk: evidence from a geospatial cross-sectional study.

Atherosclerosis plus·2026

相关实验视频

Updated: Feb 7, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.8K

性别相关的生物标志物 慢性病进展和死亡率的差异

Thomas McDonnell1,2, Anthony Onoja3, Nicolas Vuilleumier4

  • 1Donal O'Donoghue Renal Research Centre, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.

Clinical journal of the American Society of Nephrology : CJASN
|February 5, 2026
PubMed
概括

患有慢性病 (CKD) 的男性面临更高的衰竭和死亡风险. 生物标志物差异,特别是在炎症和矩阵沉积方面,解释了这些基于性别的结果差异,这表明男性CKD预后更差的生物基础.

更多相关视频

Sex Differences in Mouse Hippocampal Astrocytes after In-Vitro Ischemia
08:32

Sex Differences in Mouse Hippocampal Astrocytes after In-Vitro Ischemia

Published on: October 25, 2016

13.9K
In Vitro Method to Study Sex-Based Differences in Conjunctival Goblet Cells
06:28

In Vitro Method to Study Sex-Based Differences in Conjunctival Goblet Cells

Published on: July 28, 2023

853

相关实验视频

Last Updated: Feb 7, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.8K
Sex Differences in Mouse Hippocampal Astrocytes after In-Vitro Ischemia
08:32

Sex Differences in Mouse Hippocampal Astrocytes after In-Vitro Ischemia

Published on: October 25, 2016

13.9K
In Vitro Method to Study Sex-Based Differences in Conjunctival Goblet Cells
06:28

In Vitro Method to Study Sex-Based Differences in Conjunctival Goblet Cells

Published on: July 28, 2023

853

科学领域:

  • 腎病學和泌尿病學.
  • 生物标志物和诊断方法
  • 基于性别的医学

背景情况:

  • 与女性相比,患有慢性病 (CKD) 的男性表现较差.
  • 这种差异并不能完全由共同疾病或社会文化因素来解释.
  • 研究生物标志物的基于性别的差异可能会阐明潜在的风险机制.

研究的目的:

  • 探索特定生物标志物的基于性别的差异是否有助于男性和女性之间观察到的CKD结果差异.
  • 确定与损伤,纤维化,炎症和心血管压力相关的特定生物标志物,这些生物标志物在CKD患者的性别之间存在差异.

主要方法:

  • 分析了来自NURTuRE-CKD队列的1,680名男性和1,204名女性的非透析依赖性CKD.
  • 测量21个与损伤,纤维化,炎症和心血管应激相关的生物标志物.
  • 使用多变量Cox和Fine和Gray模型进行结果评估,并使用ANCOVA进行生物标志物比较,并根据临床因素进行调整.

主要成果:

  • 在对照组和CKD参与者中观察到生物标志物度的显著性别差异.
  • 患有CKD的男性表现出较高水平的炎症和细胞外矩阵沉积生物标志物 (例如KIM-1,GDF-15).
  • 患有CKD的女性具有较高的矩阵周转和降解标志物 (例如,骨活素,MMP-9).
  • 在调整了生物标志物差异后,消除了与男性性别相关的功能衰竭和死亡率的高风险.

结论:

  • 男性性别独立地与慢性病患者功能衰竭和死亡率增加的风险有关.
  • 性别特定的生物标志物概况反映了不同的生物途径,是这些结果差异的基础.
  • 对这些生物标志物的调整可以中和男性的风险增加,突出显示CKD性别差异的生物学基础.
  • 研究结果表明,在CKD管理中,有潜在的性别特异性治疗点.